Market Closed -
Nyse
04:00:02 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
66.08
USD
|
+1.30%
|
|
+1.71%
|
+18.32%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,582
|
3,094
|
2,635
|
2,266
|
2,424
|
2,870
|
-
|
-
|
Enterprise Value (EV)
1 |
5,017
|
4,550
|
3,841
|
3,394
|
3,537
|
4,164
|
4,195
|
4,269
|
P/E ratio
|
22.2
x
|
16.7
x
|
23.6
x
|
35.3
x
|
17.8
x
|
23
x
|
22.2
x
|
21.6
x
|
Yield
|
5.15%
|
6.38%
|
6.62%
|
6.89%
|
6.45%
|
5.45%
|
5.55%
|
5.67%
|
Capitalization / Revenue
|
11.3
x
|
9.3
x
|
8.82
x
|
8.14
x
|
7.58
x
|
8.96
x
|
8.37
x
|
7.42
x
|
EV / Revenue
|
15.8
x
|
13.7
x
|
12.9
x
|
12.2
x
|
11.1
x
|
13
x
|
12.2
x
|
11
x
|
EV / EBITDA
|
16.9
x
|
14.8
x
|
14.4
x
|
13.5
x
|
14.2
x
|
16.5
x
|
15.9
x
|
16.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.32
x
|
-
|
1.75
x
|
1.77
x
|
1.93
x
|
2.19
x
|
2.13
x
|
2.07
x
|
Nbr of stocks (in thousands)
|
43,961
|
44,729
|
45,851
|
43,389
|
43,410
|
43,425
|
-
|
-
|
Reference price
2 |
81.48
|
69.17
|
57.47
|
52.22
|
55.85
|
66.08
|
66.08
|
66.08
|
Announcement Date
|
2/19/20
|
2/22/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
318.1
|
332.8
|
298.7
|
278.2
|
319.8
|
320.4
|
342.9
|
386.6
|
EBITDA
1 |
296.8
|
308.1
|
266.6
|
251.8
|
249.6
|
252.9
|
264.3
|
261.7
|
EBIT
1 |
220
|
224.9
|
185.8
|
180.9
|
179.6
|
183.6
|
198.6
|
209.9
|
Operating Margin
|
69.17%
|
67.58%
|
62.22%
|
65.03%
|
56.16%
|
57.3%
|
57.93%
|
54.28%
|
Earnings before Tax (EBT)
1 |
160.4
|
185.3
|
112
|
65.5
|
134.4
|
120.5
|
131.7
|
135.2
|
Net income
1 |
160.5
|
185.1
|
111.8
|
66.4
|
135.6
|
125
|
132.8
|
136.3
|
Net margin
|
50.45%
|
55.62%
|
37.43%
|
23.87%
|
42.4%
|
39.02%
|
38.73%
|
35.24%
|
EPS
2 |
3.670
|
4.140
|
2.440
|
1.480
|
3.130
|
2.875
|
2.977
|
3.056
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
4.200
|
4.410
|
3.802
|
3.600
|
3.600
|
3.600
|
3.666
|
3.748
|
Announcement Date
|
2/19/20
|
2/22/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
69.67
|
71.33
|
59.9
|
76.3
|
70.67
|
82.39
|
77.88
|
80.11
|
79.46
|
81.51
|
76.44
|
77.07
|
77.63
|
84.82
|
86.96
|
EBITDA
1 |
61.3
|
61.48
|
69.44
|
61.58
|
60.06
|
62.19
|
61.21
|
63.44
|
62.76
|
64.26
|
63.38
|
63.85
|
64.25
|
64.36
|
66.17
|
EBIT
1 |
42
|
43.2
|
30.26
|
49.51
|
42.75
|
44.57
|
43.48
|
43.18
|
45.65
|
46.75
|
45.19
|
47.24
|
48.29
|
47.85
|
49.58
|
Operating Margin
|
60.29%
|
60.57%
|
50.52%
|
64.89%
|
60.5%
|
54.1%
|
55.83%
|
53.9%
|
57.45%
|
57.36%
|
59.12%
|
61.3%
|
62.21%
|
56.41%
|
57.01%
|
Earnings before Tax (EBT)
1 |
6.505
|
8.246
|
21.47
|
34.23
|
1.56
|
34.18
|
39.45
|
29.03
|
31.72
|
30.66
|
29.64
|
31.33
|
31.68
|
31.51
|
32.87
|
Net income
1 |
6.475
|
8.399
|
21.67
|
34.47
|
1.863
|
34.48
|
39.76
|
29.33
|
32.03
|
30.92
|
32
|
31.68
|
31.78
|
31.88
|
33.2
|
Net margin
|
9.29%
|
11.78%
|
36.18%
|
45.18%
|
2.64%
|
41.86%
|
51.06%
|
36.61%
|
40.3%
|
37.93%
|
41.86%
|
41.11%
|
40.94%
|
37.58%
|
38.17%
|
EPS
2 |
0.1300
|
0.1800
|
0.4700
|
0.7800
|
0.0500
|
0.7900
|
0.9200
|
0.6800
|
0.7400
|
0.7100
|
0.7183
|
0.7129
|
0.7219
|
0.7165
|
0.7425
|
Dividend per Share
2 |
0.9000
|
0.9000
|
0.9000
|
0.9000
|
0.9000
|
0.9000
|
0.9000
|
0.9000
|
0.9000
|
-
|
0.9000
|
0.9000
|
0.9000
|
0.9056
|
0.9148
|
Announcement Date
|
2/22/22
|
5/9/22
|
8/8/22
|
11/8/22
|
2/21/23
|
5/9/23
|
8/8/23
|
11/7/23
|
2/20/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,435
|
1,456
|
1,205
|
1,128
|
1,113
|
1,294
|
1,325
|
1,400
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.835
x
|
4.726
x
|
4.521
x
|
4.481
x
|
4.458
x
|
5.117
x
|
5.014
x
|
5.349
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
11.1%
|
-
|
-
|
-
|
10.7%
|
9.19%
|
9.48%
|
9.62%
|
ROA (Net income/ Total Assets)
|
5.54%
|
-
|
-
|
-
|
5.43%
|
4.67%
|
4.79%
|
4.87%
|
Assets
1 |
2,896
|
-
|
-
|
-
|
2,498
|
2,679
|
2,772
|
2,799
|
Book Value Per Share
2 |
35.10
|
-
|
32.90
|
29.50
|
28.90
|
30.20
|
31.10
|
32.00
|
Cash Flow per Share
2 |
-
|
-
|
4.610
|
4.140
|
4.250
|
4.400
|
4.610
|
4.780
|
Capex
1 |
-
|
117
|
-
|
-
|
-
|
2.6
|
2.6
|
2.6
|
Capex / Sales
|
-
|
35.07%
|
-
|
-
|
-
|
0.81%
|
0.76%
|
0.67%
|
Announcement Date
|
2/19/20
|
2/22/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
66.08
USD Average target price
66.5
USD Spread / Average Target +0.64% Consensus |
1st Jan change
|
Capi.
|
---|
| +18.32% | 2.87B | | +14.97% | 61.99B | | +0.51% | 14.01B | | +5.45% | 7.99B | | -5.80% | 6.14B | | +14.32% | 3.63B | | +2.24% | 3.38B | | +9.16% | 3.22B | | -6.13% | 3.08B | | -14.85% | 2.42B |
Healthcare REITs
|